Merck cooperates with French start-up
Generative modelling AI technology enables rapid and cost-effective design of novel drugs
15-Mar-2019 -
Merck announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds.
“This agreement is another illustration of how we aim to ...
artificial intelligence
drug design
drug discovery